What's Happening?
The Texas Rangers have re-signed right-handed reliever Josh Sborz, who was part of their 2023 World Series-winning team. Sborz, who made his Major League debut with the Los Angeles Dodgers in 2019, has faced significant challenges due to injuries, limiting
his appearances in recent years. He has not played in the Majors since 2024, with shoulder issues restricting him to minor league games. Despite these setbacks, the Rangers have opted to bring him back on a minor league deal after initially releasing him earlier this week. Sborz, now 32, has a career record of 163.1 innings pitched, averaging 10.6 strikeouts per nine innings with a 4.96 ERA. The Rangers hope he can recover and contribute to the team once again.
Why It's Important?
The re-signing of Josh Sborz by the Texas Rangers highlights the team's strategy to bolster their bullpen with experienced players who have previously contributed to their success. Sborz's return could provide the Rangers with a seasoned reliever who, if healthy, can enhance their pitching depth. This move also underscores the challenges teams face in managing player injuries and the importance of having a robust roster to navigate the long MLB season. For Sborz, this represents an opportunity to revive his career and potentially make a significant impact at the Major League level once more.
What's Next?
Josh Sborz will likely begin his journey back to the Major Leagues by proving his fitness and effectiveness in the minor leagues. The Rangers will monitor his progress closely, particularly his recovery from past shoulder issues. If Sborz can demonstrate his ability to perform consistently, he may earn a call-up to the Rangers' bullpen, providing them with additional options during the season. The team's management will also need to consider roster adjustments to accommodate Sborz's potential return to the Major League roster.
